Farnesoid X Receptor Ligand Prevents Cisplatin-Induced Kidney Injury by Enhancing Small Heterodimer Partner

The farnesoid X receptor (FXR) is mainly expressed in liver, intestine and kidney. We investigated whether 6-ethyl chenodeoxycholic acid (6ECDCA), a semisynthetic derivative of chenodeoxycholic aicd (CDCA, an FXR ligand), protects against kidney injury and modulates small heterodimer partner (SHP) i...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Bae, Eun Hui, Choi, Hong Sang, Joo, Soo Yeon, Kim, In Jin, Kim, Chang Seong, Choi, Joon Seok, Ma, Seong Kwon, Lee, JongUn, Kim, Soo Wan
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2014
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903546/
https://ncbi.nlm.nih.gov/pubmed/24475141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0086553
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы